Agenda

Please meet us at following places :

Event	Place	Date
DCAT	New York, USA	March 10-13, 2008
CPhI Worldwide 2008	Frankfurt, Germany	September 30 - October 2, 2008

News

OmniChem expands high potency capabilities & invests in new equipment

OmniChem has initiated an expansion of its center of expertise in development and manufacturing of Highly Potent APIs & Intermediates with the commissioning of a new production facility designed to handle products with an OEL down to 0,1 µg/m³/8h shift.

OmniChem currently offers on two sites capabilities in high potency :

at lab scale with brand new laboratories equipped with glove boxes;

at pilot scale (up to batch size of 50 kg) with a multipurpose containment unit having a total capacity of 2500 L equipped with vessels of 20 L to 1600 L;

at large scale (up to batch size of 250 kg), with a unit equipped with glove boxes and vessels up to 6000 L capable of handling products with an OEL down to 1 µg/m³/8h shift.

With this new State of the Art facility, OmniChem increased its capacity in handling high potency products class 5 by 4800 L, two lines of production equipped with vessels of 800 L & 1600 L will be added. Each of both lines will be segregated and equipped with Hepa filtered glove boxes.

Isolation, drying & packaging will be performed in dedicated rooms.

The building will have secured access for personnel and will integrate the most up-to-date SHE regulations.

This new investment comes in line with our strategy to stay a leader in handling of highly potent and cytotoxic compounds. We offer a full integrated service to our customers to support their GMP development & manufacturing of highly potent intermediates and APIs at all development stages.

Print this page